![Mitchell Keegan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Keegan
No open positions remaining
Profile
Mitchell Keegan worked as a Senior Director-Drug Development at Gloucester Pharmaceuticals, Inc. from 2008 to 2008.
Prior to that, he was a Pharmacology Director at CombinatoRx, Inc. from 2001 to 2005 and a Study Director at Toxikon Corp.
in 2001.
From 2008 to 2011, he worked as a Vice President-Drug Development at Curis, Inc. Keegan received his undergraduate degree from The University of Sydney and his doctorate from the University of Western Sydney.
Former positions of Mitchell Keegan
| Companies | Position | End |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 2011-10-14 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Corporate Officer/Principal | 2008-02-29 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Corporate Officer/Principal | 2005-03-31 |
Toxikon Corp.
 Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Provides life science and laboratory services | Corporate Officer/Principal | 2001-11-30 |
Training of Mitchell Keegan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toxikon Corp.
Toxikon Corp. Miscellaneous Commercial ServicesCommercial Services Provides life science and laboratory services | Commercial Services |
- Stock Market
- Insiders
- Mitchell Keegan
